Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA class I antigen expression in human solid tumors

B Klein1, I Levin, T Klein

  • 1Oncology Unit, Rabin Medical Center, Petah Tikva, Israel.

Israel Journal of Medical Sciences
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Numerical simulation of vertical cavity surface emitting lasers.

Optics express·2009
Same author

[Colonic perforation after extracorporeal shock wave lithotripsy].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

Thyroid surgery in Burkina Faso, West Africa: experience from a surgical help program.

World journal of surgery·2008
Same author

[Oocyte and embryo quality: do the apoptotic markers have a place in the preimplantation genetic diagnostic?].

Gynecologie, obstetrique & fertilite·2008
Same author

[Could apoptotic markers help the exploration of male infertility?].

Gynecologie, obstetrique & fertilite·2008
Same author

ETV6 mutations and loss in AML-M0.

Leukemia·2008
Same journal

Coronary revascularization versus conservative medical management for preoperative optimization of a patients with documented ischemic heart disease.

Israel journal of medical sciences·1998
Same journal

Primary biliary cirrhosis--association or overlap with other autoimmune diseases.

Israel journal of medical sciences·1998
Same journal

Complementary medicine--the problem and the challenge.

Israel journal of medical sciences·1998
Same journal

Electroencephalography in the evaluation of headache patients: a review.

Israel journal of medical sciences·1998
Same journal

Complementary medicine--a critical review.

Israel journal of medical sciences·1998
Same journal

The Israel Longitudinal Mortality Study--differential mortality in Israel 1983-1992: objectives, materials, methods and preliminary results.

Israel journal of medical sciences·1998
See all related articles

Reduced expression of Human Leukocyte Antigen (HLA) class I antigens in various cancers correlates with tumor aggressiveness and poor prognosis. However, irradiation of brain tumors increased HLA class I expression.

Area of Science:

  • Oncology
  • Immunology
  • Pathology

Background:

  • Human Leukocyte Antigen (HLA) class I antigens play a crucial role in immune surveillance.
  • Aberrant expression of HLA class I is observed in various malignancies.
  • Understanding HLA class I expression patterns can offer insights into tumor behavior and patient outcomes.

Purpose of the Study:

  • To investigate the expression of HLA class I antigens in diverse tumor types.
  • To correlate HLA class I expression with clinicopathologic features and patient survival.
  • To explore the impact of therapeutic interventions like irradiation on HLA class I expression.

Main Methods:

  • Immunohistochemistry was employed to assess HLA class I antigen expression in tumor tissues.
  • Correlation analysis was performed between HLA class I expression levels and clinicopathologic characteristics (aggressiveness, grade, invasion).

Related Experiment Videos

  • Soluble HLA class I levels were measured in patients with breast and colon cancer.

    • Main Results:

    • Reduced HLA class I expression was noted in germ cell testicular, kidney, prostate, gastric, and colon cancers, linked to increased tumor aggressiveness and invasiveness.
    • In bladder cancer, diminished HLA class I expression correlated with poorer patient survival.
    • Irradiation of brain tumors led to an upregulation of HLA class I expression.
    • Elevated soluble HLA class I levels were detected in patients with metastatic breast and colon cancer.

    Conclusions:

    • Reduced HLA class I expression is a marker of aggressive disease and poor prognosis in several cancer types.
    • HLA class I expression is modulated by therapeutic interventions such as irradiation.
    • Soluble HLA class I levels may indicate the presence and extent of metastatic disease.